N1 Investment Company

VC Lisbon, Portugal · Founded 2018

Website

N1 Investment Company backs early-stage European founders building scalable, high-potential technology startups in SaaS, AI/ML, and non-clinical HealthTech. They act as strategic partners, providing hands-on operational support and go-to-market execution alongside capital.

About N1 Investment Company

N1 Investment Company, also visible under the Nation 1 brand, is a US investment vehicle with a footprint that suggests a small fund or family office active across early-stage technology and selective healthcare opportunities. Without disclosed thesis, stage, or check-size data, the most honest read is that this is a relationship-driven investor rather than a programmatic institutional fund. Healthcare exposure is unstated and likely opportunistic; expect openness to AI-native digital health and healthtech where the company has strong founder credibility and scaling potential, but limited specialist clinical or regulatory diligence capacity. AI focus is plausibly real given typical naming conventions for funds positioning around frontier technology. Anchoring to typical small-vehicle norms, expect pre-seed and seed checks plausibly in the USD 100K to USD 500K range, often co-investing rather than leading. This is the wrong door for therapeutics, devices, or hospital enterprise plays where deep healthcare expertise is the unlock. It is a plausible co-investor for early healthcare software founders who already have a healthcare-credible lead and want additional generalist conviction on the cap table. Entry path is the website contact and direct LinkedIn outreach; warm introductions from shared networks materially raise the probability of a substantive conversation. Founders should be candid about whether the firm’s generalist orientation truly serves their commercialization path and should not over-invest time without a relationship signal.